ENTITY
Shenzhen Hepalink Pharmaceutical

Shenzhen Hepalink Pharmaceutical (9989 HK)

97
Analysis
Health Care • China
Shenzhen Hepalink Pharmaceutical is a multinational biopharmaceutical company with core businesses in the heparin industrial chain, large molecule biologics CDMO services, and the research, development, and commercialization of innovative drugs. Its key products include heparin sodium APIs and enoxaparin sodium preparations. The company is headquartered in Shenzhen, China, and was founded in 1998.
more
•08 Mar 2026 10:15

A-H Premium Weekly (Mar 6th): Sinopec, COSCO Shipping Energy, China Coal Energy, CNOOC

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Sinopec, COSCO Shipping Energy, China Coal Energy, CNOOC,...

Logo
290 Views
Share
•15 Feb 2026 10:15

A-H Premium Weekly (Feb 13th): Shanghai Electric, China Energy Engineering, Sinotrans, BYD

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Shanghai Electric, China Energy Engineering, Sinotrans, BYD,...

Logo
346 Views
Share
bullish•BYD Company
•10 Feb 2026 13:51

A/H Premium Tracker (2 Weeks to 6 Feb 2026):Ā  Slight H/A Under-Perf

AH premia were down two weeks ago, and back up last week. Hs have underperformed ytd but the Quiddity Portfolio is up. I suggest staying long...

Logo
350 Views
Share
•01 Feb 2026 10:15

A-H Premium Weekly (Jan 30th): China Railway, CNOOC, Ningbo Joyson Electronic, YOFC, Tianqi Lithium

We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Railway, CNOOC, Ningbo Joyson Electronic, YOFC, Tianqi...

Logo
234 Views
Share
•26 Jan 2026 12:15

A/H Premium Tracker (Week to 23 Jan 2026):Ā  Slight H/A Outperf, Quiddity Port Still Better

Hs outperformed As last week so are just up on the year on average for liquid pairs. Quiddity Portfolio doing better. Beautiful skew is absent...

Logo
339 Views
Share
x